Biography

Prof. Dr. Kenneth Blum

Western University Health Sciences, USA


Email: drd2gene@gmail.com


Qualifications

1972 Post Doctorate, Texas Biomedical Research Institute, USA

1968 Ph.D., New York Medical College, USA

1965 M.S., The University of Medicine and Dentistry of New Jersey, USA

1961 B.S., Columbia University, USA


Publications (Selected)

  1. Martire, G., Sipple, D., Baron, D., Gold, M. S., Lewandowski, K. U., Dennen, C. A., Sharafshah, A., Elman, I., Thanos, P. K., Modestino, E. J., Badgaiyan, R. D., Pinhasov, A., Bowirrat, A., Makale, M., Roy, A. K., Sunder, K., Murphy, K. T., Mahajan, S., Mahajan, Y., Levin, C., … Blum, K. (2024). Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders. Journal of addiction psychiatry, 8(2), 161–165.
  2. Zeine, F., Jafari, N., Baron, D., Bowirrat, A., Pinhasov, A., Norling, B., Martinez, K. C., Nami, M., Manavi, N., Sunder, K., Rabin, D. M., Bagchi, D., Khalsa, J., Gold, M. S., Sipple, D., Barzegar, M., Bodhanapati, J., Khader, W., Carney, P., Dennen, C. A., … Blum, K. (2024). Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy. Journal of addiction psychiatry, 8(1), 50–95.
  3. Blum K, Thanos PK, Hanna C, Gold MS, Baron D, Elman I. “TO BE OR NOT TO BE” GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS). Psychol Res Behav Manag. 2023;16:4287-4291 https://doi.org/10.2147/PRBM.S428841
  4. Senior, D., Ahmed, R., Arnavut, E., Carvalho, A., Lee, W. X., Blum, K., Komatsu, D. E., Hadjiargyrou, M., Badgaiyan, R. D., & Thanos, P. K. (2023). Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review. Journal of Personalized Medicine, 13(4), 574. https://doi.org/10.3390/jpm13040574
  5. Hanna, C., Hamilton, J., Blum, K., Badgaiyan, R. D., & Thanos, P. K. (2022). Exercise Modulates Brain Glucose Utilization Response to Acute Cocaine. Journal of Personalized Medicine, 12(12), 1976. https://doi.org/10.3390/jpm12121976
  6. Bajaj, A., Blum, K., Bowirrat, A., Gupta, A., Baron, D., Fugel, D., Nicholson, A., Fitch, T., Downs, B. W., Bagchi, D., Dennen, C. A., & Badgaiyan, R. D. (2022). DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave® and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of “Dopamine Homeostasis” in the Face of the Opioid Crisis. Journal of Personalized Medicine, 12(9), 1416. https://doi.org/10.3390/jpm12091416
  7. Blum K, Kazmi S, Modestino EJ, Downs BW, Bagchi D, Baron D, McLaughlin T, Green R, Jalali R, Thanos PK, Elman I, Badgaiyan RD, Bowirrat A, Gold MS. A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. Journal of Personalized Medicine. 2021; 11(3):212. https://doi.org/10.3390/jpm11030212.
  8. Blum K, Chen TJ, Morse S, Giordano J, Chen AL, Thompson J, Allen C, Smolen A, Lubar J, Stice E, Downs BW, Waite RL, Madigan MA, Kerner M, Fornari F, Braverman ER. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂agonist therapy: part 2. Postgrad Med. 2010 Nov;122(6):214-26. doi: 10.3810/pgm.2010.11.2237. PMID: 21084796.
  9. Brittany Richardson, Sabrina Swenson, John Hamilton, Ken Leonard, Foteini Delis, Mark Gold, Ken Blum, Panayotis K. Thanos,Chronic neuroleptic treatment combined with a high fat diet elevated [3H] flunitrazepam binding in the cerebellum,Progress in Neuro-Psychopharmacology and Biological Psychiatry,Volume 112,2022,110407,ISSN 0278-5846,https://doi.org/10.1016/j.pnpbp.2021.110407.
  10. Richardson B, Swenson S, Hamilton J, Leonard K, Delis F, Gold M, Blum K, Thanos PK. Chronic neuroleptic treatment combined with a high fat diet elevated [3H] flunitrazepam binding in the cerebellum. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 25;112:110407. doi: 10.1016/j.pnpbp.2021.110407. Epub ahead of print. PMID: 34320402.
  11. Blum K, Raza A, Schultz T, Jalali R, Green R, Brewer R, Thanos PK, McLaughlin T, Baron D, Bowirrat A, Elman I, Downs BW, Bagchi D, Badgaiyan RD. Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality? Acta Sci Neurol. 2021 Feb 2;4(2):17-24. PMID: 33681869; PMCID: PMC7931265.
  12. Blum K, Khalsa J, Cadet JL, Baron D, Bowirrat A, Boyett B, Lott L, Brewer R, Gondré-Lewis M, Bunt G, Kazmi S, Gold MS. Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis. Front Psychiatry. 2021 Mar 30;12:623403. doi: 10.3389/fpsyt.2021.623403. PMID: 33868044; PMCID: PMC8044913.
  13. Moran M, Blum K, Ponce JV, Lott L, Gondré-Lewis MC, Badgaiyan S, Brewer R, Downs BW, Fynman P, Weingarten A, Cadet JL, Smith DE, Baron D, Thanos PK, Modestino EJ, Badgaiyan RD, Elman I, Gold MS. High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial. Mol Neurobiol. 2021 Jul;58(7):3335-3346. doi: 10.1007/s12035-021-02312-1. Epub 2021 Mar 8. PMID: 33683627; PMCID: PMC8257535.
  14. Blum K, Kazmi S, Modestino EJ, Downs BW, Bagchi D, Baron D, McLaughlin T, Green R, Jalali R, Thanos PK, Elman I, Badgaiyan RD, Bowirrat A, Gold MS. A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration. J Pers Med. 2021 Mar 16;11(3):212. doi: 10.3390/jpm11030212. PMID: 33809702; PMCID: PMC8002215.
  15. Blum K, Morgan J, Cadet JL, Baron D, Carney PR, Khalsa J, Badgaiyan RD, Gold MS. Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220). Neurology (ECronicon). 2021 Apr;13(4):86-92. Epub 2021 Mar 31. PMID: 34085060; PMCID: PMC8171216.
  16. Blum K, Cadet JL, Gold MS. Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. J Neurol Sci. 2021 Jan 15;420:117252. doi: 10.1016/j.jns.2020.117252. Epub 2020 Nov 28. PMID: 33279726.
  17. Blum K, Thanos PK, Oscar-Berman M, Febo M, Baron D, Badgaiyan RD, Gardner E, Demetrovics Z, Fahlke C, Haberstick BC, Dushaj K, Gold MS. Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. J Reward Defic Syndr. 2015;1(3):95-104. doi: 10.17756/jrds.2015-016. Epub 2015 Oct 23. PMID: 27398406; PMCID: PMC4936401.
  18. Downs BW, Kushner S, Bagchi M, Blum K., Badgaiyan RD, Bagchi D. Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise. Current Psychopharmacology, 2021, 10, 1-15 1.
  19. Madigan MA, Badgaiyan RD, Baron D, Blum, K., Precision Behavioral Management (PBM) A Novel Approach to Combat Post-Traumatic Stress Disorder (PTSD). SOJ Psychol. 2018;5(2):10.15226/2374-6874/5/2/00148. doi: 10.15226/2374-6874/5/2/00148. Epub 2018 Aug 6. PMID: 31440582; PMCID: PMC6706091.


Profile Details

https://www.researchgate.net/profile/Kenneth-Blum
https://orcid.org/0000-0001-6727-803X
https://sciprofiles.com/profile/26810

Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top